Commentary by Bani Chander MD, PGY-2, and Sergio Obligado MD, Attending Physician, Nephrology
Tumor lysis syndrome (TLS) is characterized by a group of metabolic abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia with secondary hypocalcemia, …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Commentary by Jacqueline Friedman, MD, Clinical Associate Professor of Neurology, Director, New York Region Veterans Administration Multiple Sclerosis Center of Excellence
Commentary by Rosemary Adamson, PGY2, Â Deena Altman PGY-1 and Harold Horowitz, Professor of Medicine, Section of Infectious DiseasesÂ
Commentary by Melissa Freeman MD, PGY2
Commentary by William Slater, MD Associate Professor of Medicine, Divsion of Cardiology